NDRA dividend history
ENDRA Life Sciences Inc. (NDRA) dividend declarations and ex-dividend dates - real-time wire coverage of every payout disclosure.
Recent dividend items
- ENDRA Life Sciences Reports First Quarter 2021 Financial Results and Provides Business UpdateConference call begins at 4:30 p.m. Eastern time todayANN ARBOR, MI / ACCESSWIRE / May 17, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three months ended March 31, 2021 and provided a business update. Highlights of the first quarter of 2021 and recent weeks include the following:Began screening patients for real-world clinical validation of TAEUS at Rocky Vista University College of Osteopathic Medicine. All clinical evaluation sites will compare the liver fat measurements of the TAEUS system to the gold standard MRI-PDFF.Partnered with Hepion Pharmaceuticals, a clinical-stage com
- ENDRA Life Sciences Reports 2020 Fourth Quarter and Full Year Financial Results, Provides Business UpdateConference call begins at 4:30 p.m. Eastern time today ANN ARBOR, MI / ACCESSWIRE / March 25, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reported financial results for the three and twelve months ended December 31, 2020 and provided a business update. Highlights of the fourth quarter of 2020 and recent weeks include the following: Partnered with Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical-stage biopharmaceutical company focused on AI-driven therapeutic drug development for the treatment of NASH and liver disease. ENDRA signed a collaboration agreement with Hepion to incorporate TAEUS as an add-on te